JPH01258691A - Phospholipid derivative and production thereof - Google Patents
Phospholipid derivative and production thereofInfo
- Publication number
- JPH01258691A JPH01258691A JP63083136A JP8313688A JPH01258691A JP H01258691 A JPH01258691 A JP H01258691A JP 63083136 A JP63083136 A JP 63083136A JP 8313688 A JP8313688 A JP 8313688A JP H01258691 A JPH01258691 A JP H01258691A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- oxy
- tetrahydro
- glycerophosphorylcholine
- bilan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003904 phospholipids Chemical class 0.000 title claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 239000002253 acid Substances 0.000 claims abstract description 4
- 125000006239 protecting group Chemical group 0.000 claims abstract description 4
- 239000008777 Glycerylphosphorylcholine Substances 0.000 claims description 39
- 229960004956 glycerylphosphorylcholine Drugs 0.000 claims description 39
- 239000000126 substance Substances 0.000 claims description 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 7
- 239000000194 fatty acid Substances 0.000 claims description 7
- 229930195729 fatty acid Natural products 0.000 claims description 7
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 abstract description 9
- -1 aliphatic anhydride Chemical class 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 3
- 239000012190 activator Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 238000001819 mass spectrum Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000000921 elemental analysis Methods 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- 150000008065 acid anhydrides Chemical class 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000004817 gas chromatography Methods 0.000 description 6
- 238000002329 infrared spectrum Methods 0.000 description 6
- PBBAFLCORNAZCD-UHFFFAOYSA-N nonanoyl nonanoate Chemical compound CCCCCCCCC(=O)OC(=O)CCCCCCCC PBBAFLCORNAZCD-UHFFFAOYSA-N 0.000 description 6
- 238000010898 silica gel chromatography Methods 0.000 description 6
- 239000006227 byproduct Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- RIZOOQYPYGPBOC-UHFFFAOYSA-N methyl 9-hydroxynonanoate Chemical compound COC(=O)CCCCCCCCO RIZOOQYPYGPBOC-UHFFFAOYSA-N 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000003998 snake venom Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- ZDHCZVWCTKTBRY-UHFFFAOYSA-N 12-hydroxylauric acid Chemical compound OCCCCCCCCCCCC(O)=O ZDHCZVWCTKTBRY-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- UGUYQBMBIJFNRM-OQFOIZHKSA-N [(z)-but-2-en-2-yl]benzene Chemical compound C\C=C(\C)C1=CC=CC=C1 UGUYQBMBIJFNRM-OQFOIZHKSA-N 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 2
- SUHOQUVVVLNYQR-MRVPVSSYSA-N choline alfoscerate Chemical compound C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- NWADXBLMWHFGGU-UHFFFAOYSA-N dodecanoic anhydride Chemical compound CCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCC NWADXBLMWHFGGU-UHFFFAOYSA-N 0.000 description 2
- PKHMTIRCAFTBDS-UHFFFAOYSA-N hexanoyl hexanoate Chemical compound CCCCCC(=O)OC(=O)CCCCC PKHMTIRCAFTBDS-UHFFFAOYSA-N 0.000 description 2
- RXIZPTUJJOZXSR-UHFFFAOYSA-N methyl 6-(oxan-2-yloxy)hexanoate Chemical compound COC(=O)CCCCCOC1CCCCO1 RXIZPTUJJOZXSR-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229940057303 naja naja venom Drugs 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 2
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- ZITIQCQEVOLWQQ-UHFFFAOYSA-N 6-(oxan-2-yloxy)hexanoic acid Chemical compound OC(=O)CCCCCOC1CCCCO1 ZITIQCQEVOLWQQ-UHFFFAOYSA-N 0.000 description 1
- IWHLYPDWHHPVAA-UHFFFAOYSA-N 6-hydroxyhexanoic acid Chemical compound OCCCCCC(O)=O IWHLYPDWHHPVAA-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 102100037611 Lysophospholipase Human genes 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- HTWWKYKIBSHDPC-UHFFFAOYSA-N decanoyl decanoate Chemical compound CCCCCCCCCC(=O)OC(=O)CCCCCCCCC HTWWKYKIBSHDPC-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- QWZBEFCPZJWDKC-UHFFFAOYSA-N hexadecanoyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCCCC QWZBEFCPZJWDKC-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- AUONNNVJUCSETH-UHFFFAOYSA-N icosanoyl icosanoate Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCCCCCCCC AUONNNVJUCSETH-UHFFFAOYSA-N 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WVYBBOXJKXXXOY-UHFFFAOYSA-N methyl 12-hydroxydodecanoate Chemical compound COC(=O)CCCCCCCCCCCO WVYBBOXJKXXXOY-UHFFFAOYSA-N 0.000 description 1
- CEBHOHNBIXSCRE-UHFFFAOYSA-N methyl 2-hydroxynonanoate Chemical compound CCCCCCCC(O)C(=O)OC CEBHOHNBIXSCRE-UHFFFAOYSA-N 0.000 description 1
- YDJZXHZRXDLCEH-UHFFFAOYSA-N methyl 6-hydroxyhexanoate Chemical compound COC(=O)CCCCCO YDJZXHZRXDLCEH-UHFFFAOYSA-N 0.000 description 1
- 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WVJVHUWVQNLPCR-UHFFFAOYSA-N octadecanoyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCCCCCC WVJVHUWVQNLPCR-UHFFFAOYSA-N 0.000 description 1
- RAFYDKXYXRZODZ-UHFFFAOYSA-N octanoyl octanoate Chemical compound CCCCCCCC(=O)OC(=O)CCCCCCC RAFYDKXYXRZODZ-UHFFFAOYSA-N 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- RCRYHUPTBJZEQS-UHFFFAOYSA-N tetradecanoyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCC RCRYHUPTBJZEQS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、薬理学的に有効な新規なリン脂質誘導体及び
その製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a novel pharmacologically effective phospholipid derivative and a method for producing the same.
(従来の技術)
績胞膜の脂質中には下記の構造式:
(式中、R,はアルキル基を示し、Rzは不飽和炭化水
素基を示す、)で表されるリン脂質化合物が多く存在し
ており、生体内酸化反応により式中の2位の不飽和炭化
水素基R2が種々の官能基に置換され、薬理学的に有効
である化合物が生成する。(Prior art) There are many phospholipid compounds represented by the following structural formula: (wherein R represents an alkyl group and Rz represents an unsaturated hydrocarbon group) in the lipids of the vesicle membrane. The unsaturated hydrocarbon group R2 at the 2-position in the formula is substituted with various functional groups by an in vivo oxidation reaction, producing pharmacologically effective compounds.
(発明が解決しようとする課題)
しかしながら、これまでに前記式中の2位に官能基を有
するリン脂質化合物の製造に成功した報告はなされてい
ない。(Problems to be Solved by the Invention) However, there has been no report to date on the successful production of a phospholipid compound having a functional group at the 2-position in the above formula.
本発明の目的は、前記式中の2位に官能基を有する薬理
学的に有効な新規なリン脂質誘導体及びその製造方法を
提供することにある。An object of the present invention is to provide a novel pharmacologically effective phospholipid derivative having a functional group at the 2-position in the above formula, and a method for producing the same.
(課題を解決するための手段)
本発明の薬理学的に有効な新規なリン脂質誘導体は次の
構造式(1)で表されるような2位にヒドロキシル基を
有する化合物である。(Means for Solving the Problems) The novel pharmacologically effective phospholipid derivative of the present invention is a compound having a hydroxyl group at the 2-position as represented by the following structural formula (1).
1 ′″
(式中、mは1〜22、nは1〜22である。)また、
本発明は次の一般式:
(式中、mは1〜22、nは1〜22である)で表され
るような2位に特定の置換基を有する化合物である。1'' (wherein, m is 1 to 22, and n is 1 to 22).
The present invention is a compound having a specific substituent at the 2-position as represented by the following general formula: (wherein m is 1-22 and n is 1-22).
上記(1)、(II)の式中、mは1〜22、nは1〜
22であるが、この範囲外では薬理学的な有効性に乏し
い。In the formulas (1) and (II) above, m is 1 to 22, and n is 1 to
22, but it lacks pharmacological effectiveness outside this range.
本発明のリン脂質誘導体(Hおよび(n)は、以下に記
載する方法によって製造することができる。The phospholipid derivatives (H and (n)) of the present invention can be produced by the method described below.
すなわち、次の一般式
%式%)
(式中、mは1〜22である。)
で表される1−モノアシル−3−グリセロホスホリルコ
リン(III)を3級アミンの存在下で、次の一般式;
(式中、nは1〜・22である。)
で表される保護基を有する脂肪酸無水物と反応させ、式
(II)の化合物を得る0次に酸処理を行うことで、ピ
ラニル基を脱離させ、目的とするリン脂質(I)を得る
。That is, in the presence of a tertiary amine, 1-monoacyl-3-glycerophosphorylcholine (III) represented by the following general formula (% formula %) (where m is 1 to 22) is converted to the following general formula: (In the formula, n is 1 to 22.) By reacting with a fatty acid anhydride having a protecting group represented by the formula (II) to obtain a compound of formula (II), pyranyl The group is removed to obtain the desired phospholipid (I).
合成経路を下図に示す。The synthetic route is shown in the figure below.
−(m)
(II)
(式中、mは1〜22、nは1〜22である。)第1工
程の反応における反応温度及び反応時間は通常は30〜
100℃、2〜48時間であるが、より好ましくは40
〜70℃で、2〜8時間である。30℃未満又は2時間
未満では未反応物が多く、100℃を超えたり48時間
を超える場合は副生成物が多くなるなどで収率が低下す
る。第2工程の酸処理については、反応温度及び反応時
間は、通常0℃〜70℃、1−10時間であるが、より
好ましくは30〜50℃、2〜5時間である。0℃未満
又は1時間未満では未反応物が多く、70℃を超えたり
10時間を超える場合は副生成物が多くなるなどで収率
が低下する。-(m) (II) (In the formula, m is 1 to 22, and n is 1 to 22.) The reaction temperature and reaction time in the first step reaction are usually 30 to
100°C for 2 to 48 hours, more preferably 40
~70°C for 2 to 8 hours. If the temperature is less than 30°C or less than 2 hours, there will be a large amount of unreacted materials, and if the temperature is more than 100°C or more than 48 hours, by-products will increase and the yield will decrease. Regarding the acid treatment in the second step, the reaction temperature and reaction time are usually 0°C to 70°C and 1 to 10 hours, more preferably 30 to 50°C and 2 to 5 hours. If the temperature is less than 0°C or less than 1 hour, there will be a large amount of unreacted substances, and if the temperature is more than 70°C or more than 10 hours, by-products will increase and the yield will decrease.
一般式(I[I)で表される1−モノアシル−3−グリ
セロホスホリルコリンとしては、例えば1−プロパノイ
ル−3−グリセロホスホリルコリン、1−ヘキサノイル
−3−グリセロホスホリルコリン、1−ノナノイル−3
−グリセロホスホリルコリン、1−ドデカノイル−3−
グリセロホスホリルコリン、1−テトラデカノイル−3
−グリセロホスホリルコリン、1−ヘキサデカノイル−
3−グリセロホスホリルコリン、1−オクタデカノイル
−3−グリセロホスホリルコリン、1−エイコサノイル
−3−グリセロホスホリルコリン、1−ドコサノイル−
3−グリセロホスホリルコリンなどが挙げられる。Examples of the 1-monoacyl-3-glycerophosphorylcholine represented by the general formula (I[I) include 1-propanoyl-3-glycerophosphorylcholine, 1-hexanoyl-3-glycerophosphorylcholine, and 1-nonanoyl-3
-glycerophosphorylcholine, 1-dodecanoyl-3-
Glycerophosphorylcholine, 1-tetradecanoyl-3
-Glycerophosphorylcholine, 1-hexadecanoyl-
3-glycerophosphorylcholine, 1-octadecanoyl-3-glycerophosphorylcholine, 1-eicosanoyl-3-glycerophosphorylcholine, 1-docosanoyl-
Examples include 3-glycerophosphorylcholine.
酸無水物(rV)は以下の方法により得ることができる
0合成経路を下図に示す。Acid anhydride (rV) can be obtained by the following method. The synthetic route is shown in the figure below.
(IV)
(式中、kはθ〜4、nは1〜22である。)最初の付
加反応に於ける反応温度及び、反応時間は、通常O〜6
0℃、1〜7時間であるが、より好ましくは10〜30
℃、1〜3時間である。0℃未満又は1時間未満では未
反応物が多く、60℃を超えたり7時間を超える場合は
副生成物が多くなるなどで収率が低下する。(IV) (In the formula, k is θ~4, and n is 1~22.) The reaction temperature and reaction time in the first addition reaction are usually 0~6
0°C, 1 to 7 hours, more preferably 10 to 30 hours
°C for 1 to 3 hours. If the temperature is less than 0°C or less than 1 hour, there will be a large amount of unreacted materials, and if the temperature exceeds 60°C or more than 7 hours, the yield will decrease due to increased amount of by-products.
アルカリ加水分解の反応は、通常10〜70℃、1〜2
4時間であるが、より好ましくは20〜50℃、2〜1
0時間である。10℃未満又は1時間未満では未反応物
が多く、70℃を超えたり24時間を超える場合は副生
成物が多くなるなどで収率が低下する。The alkaline hydrolysis reaction is usually carried out at 10 to 70°C and 1 to 2
4 hours, more preferably 20-50°C, 2-1
It is 0 hours. If it is less than 10°C or less than 1 hour, there will be a large amount of unreacted substances, and if it is more than 70°C or more than 24 hours, by-products will increase and the yield will decrease.
酸無水物化の反応は通常10〜70℃、1〜24時間で
あるが、より好ましくは30〜50℃、3〜12時間で
ある。10℃未満又は1時間未満では未反応物が多(,
70℃を超えたり24時間を超える場合は副生成物が多
くなるなどで収率が低下する。The acid anhydride reaction is usually carried out at 10 to 70°C for 1 to 24 hours, more preferably at 30 to 50°C for 3 to 12 hours. If it is less than 10℃ or less than 1 hour, there will be a lot of unreacted substances (,
When the temperature exceeds 70°C or exceeds 24 hours, the yield decreases due to increased amount of by-products.
酸無水物(rV)としては、3−((テトラヒドロ−2
1(−ビラン−2−イル)オキシ)プロピオン酸無水物
、6−((テトラヒドロ−2H−ビラン−2−イル)オ
キシ)ヘキサン酸無水物、8−((テトラヒドロ−2H
−ビラン−2−イル)オキシ)オクタン酸無水物、9−
((テトラヒドロ−2I]−ビラン−2−イル)オキシ
)ノナン酸無水物、1〇−((テトラヒドロ−2H−ビ
ラン−2〜イル)オキシ)デカン酸無水物、12−((
テトラヒドロ−2H−ビラン−2−イル)オキシ)ドデ
カン酸無水物、14−((テトラヒドロ−2H−ビラン
−2−イル)オキシ)テトラデカン酸無水物、16−(
(テトラヒドロ−2H−ビラン−2−イル)オキシ)ヘ
キサデカン酸無水物、1s−ccテトラヒドロ−2H−
ビラン−2−イル)オキシ)オクタデカン酸無水物、2
O−((テトラヒドロ−2H−ビラン−2−イル)オキ
シ)エイコサン酸無水物、21((テトラヒドロ−2H
−ビラン−2−イル)オキシ)トコサン酸無水物などが
挙げられる。As the acid anhydride (rV), 3-((tetrahydro-2
1(-bilan-2-yl)oxy)propionic anhydride, 6-((tetrahydro-2H-bilan-2-yl)oxy)hexanoic anhydride, 8-((tetrahydro-2H
-bilan-2-yl)oxy)octanoic anhydride, 9-
((Tetrahydro-2I]-bilan-2-yl)oxy)nonanoic anhydride, 10-((tetrahydro-2H-bilan-2-yl)oxy)decanoic anhydride, 12-((
Tetrahydro-2H-bilan-2-yl)oxy)dodecanoic anhydride, 14-((tetrahydro-2H-bilan-2-yl)oxy)tetradecanoic anhydride, 16-(
(tetrahydro-2H-bilan-2-yl)oxy)hexadecanoic anhydride, 1s-cctetrahydro-2H-
biran-2-yl)oxy)octadecanoic anhydride, 2
O-((tetrahydro-2H-bilan-2-yl)oxy)eicosanoic anhydride, 21((tetrahydro-2H
-bilan-2-yl)oxy)tocosanoic acid anhydride and the like.
また、本発明の製造方法において第1工程で用いる3級
アミンとしては、トリエチルアミン、トリメチルアミン
、ピリジン、4−ジメチルアミノピリジンなどが挙げら
れる。第2工程の酸処理に用いる酸としては、塩酸、硫
酸、酢酸、トリフロロ酢酸、リン酸、p−トルエンスル
ホン酸などが挙げられる。Furthermore, examples of the tertiary amine used in the first step in the production method of the present invention include triethylamine, trimethylamine, pyridine, and 4-dimethylaminopyridine. Examples of acids used in the acid treatment in the second step include hydrochloric acid, sulfuric acid, acetic acid, trifluoroacetic acid, phosphoric acid, and p-toluenesulfonic acid.
反応終了後、反応混合物を濃縮し、残留物をシリカゲル
クロマトグラフィ等の分離手段により精製することで、
目的物(1)、(II)の純品を得ることができる。After the reaction is completed, the reaction mixture is concentrated and the residue is purified by separation means such as silica gel chromatography.
Pure objects (1) and (II) can be obtained.
(発明の効果)
本発明のリン脂質誘導体は新規な物質であり、免疫賦活
剤としての効力を有し、薬理学的に極めて有用な化合物
である。(Effects of the Invention) The phospholipid derivative of the present invention is a novel substance, has efficacy as an immunostimulant, and is a pharmacologically extremely useful compound.
また、本発明の新規なリン脂質誘導体の製造方法は、少
ない工程数で、しかも容易に入手できる原料を使用して
、高収率・高純度で前記リン脂質誘導体を得ることがで
き、工業的に極めて有用な製法である。In addition, the novel method for producing phospholipid derivatives of the present invention allows the phospholipid derivatives to be obtained in high yield and purity using a small number of steps and using easily available raw materials, and is suitable for industrial use. This is an extremely useful manufacturing method.
(実施例)
以下、実施例及び比較例をあげて本発明をさらに具体的
に説明する。(Examples) Hereinafter, the present invention will be explained in more detail by giving Examples and Comparative Examples.
実施例1
攪拌子の入った200d活栓付ナス形フラスコに、9−
ヒドロキシノナン酸メチル14.0g、 p −)ルエ
ンスルホン酸204■、3.4−ジヒドロ−2H−ビラ
ン12.3g及びベンゼン130−を導入し、室温で2
時間攪拌した0反応終了後、減圧下でベンゼンを留去し
た0次いで反応混合物をシリカゲルカラムクロマト(展
開液;n−ヘキサン:ジエチルエーテル=80:20(
容積比))で分離したところ、9−((テトラヒドロ−
2H−ビラン−2−イル)オキシ)ノナン酸メチル12
.45g (収率61.6%)を得た。Example 1 9-
14.0 g of methyl hydroxynonanoate, 204 g of p-)luenesulfonic acid, 12.3 g of 3,4-dihydro-2H-bilane and 130 g of benzene were introduced, and 2
After the reaction was stirred for an hour, benzene was distilled off under reduced pressure.The reaction mixture was then subjected to silica gel column chromatography (developing solution: n-hexane: diethyl ether = 80:20).
When separated by volume ratio)), 9-((tetrahydro-
Methyl 2H-bilan-2-yl)oxy)nonanoate 12
.. 45 g (yield 61.6%) was obtained.
攪拌子の入った10〇−活栓付ナス型フラスコに9−(
(テトラヒドロ−2H−ビラン−2−イル)オキシ)ノ
ナン酸メチル5.86 g、水酸化カリウム2.23
g及び、水30−を導入し室温で12時間攪拌した0反
応終了後、ジエチルエーテルで洗浄した。9-(
Methyl (tetrahydro-2H-bilan-2-yl)oxy)nonanoate 5.86 g, potassium hydroxide 2.23
After the completion of the reaction, 30 g of water and 30 g of water were introduced and stirred at room temperature for 12 hours, and the mixture was washed with diethyl ether.
反応液を2Nの硫酸水溶液でpH3〜4とした後、ジエ
チルエーテルで抽出し濃縮した。濃縮液をシリカゲルカ
ラムクロマト(展開液;n−ヘキサン:ジエチルエーテ
ル−70: 30 (容量比))で分離したところ、3
9−((テトラヒドロ−2H−ビラン−2−イル)オキ
シ)ノナン酸4.03g (収率72.5%)を得た。The reaction solution was adjusted to pH 3 to 4 with a 2N aqueous sulfuric acid solution, extracted with diethyl ether, and concentrated. When the concentrated solution was separated using silica gel column chromatography (developing solution: n-hexane:diethyl ether-70:30 (volume ratio)), 3
4.03 g (yield 72.5%) of 9-((tetrahydro-2H-bilan-2-yl)oxy)nonanoic acid was obtained.
攪拌子の入った100mJ!活栓付ナス型フラスコに9
−((テトラヒドロ−2H−ビラン−2−イル)オキシ
)ノナン酸3.50g、 N、 N’−ジシクロへキシ
ルカルボジイミド2.81 g及び、四塩化炭素6〇−
を導入し、室温で15時間、反応させた。反応終了後、
析出する白色固体を濾過により除去して、9−((テト
ラヒドロ−2H−ビラン−2−イル)オキシ)ノナン酸
無水物の四塩化炭素溶液を得た。100mJ with stirring bar! 9 in an eggplant-shaped flask with a stopcock
-((tetrahydro-2H-bilan-2-yl)oxy)nonanoic acid 3.50 g, N,N'-dicyclohexylcarbodiimide 2.81 g, and carbon tetrachloride 60-
was introduced and allowed to react at room temperature for 15 hours. After the reaction is complete,
The precipitated white solid was removed by filtration to obtain a carbon tetrachloride solution of 9-((tetrahydro-2H-bilan-2-yl)oxy)nonanoic anhydride.
適量の四塩化炭素溶液を採集し、減圧下で四塩化炭素を
留去したところ、9−((テトラヒドロ−214−ビラ
ン−2−イル)オキシ)ノナン酸無水物2.48 gを
得た。これに、1−オクタデカノイル−3−グリセロホ
スホリルコリン1.30g5N、N′−ジメチルアミノ
ビリジン0.624g及び、ジメチルスルホキシド12
−を加え、50℃で6時間攪拌した。An appropriate amount of carbon tetrachloride solution was collected and carbon tetrachloride was distilled off under reduced pressure to obtain 2.48 g of 9-((tetrahydro-214-bilan-2-yl)oxy)nonanoic anhydride. To this, 1.30 g of 1-octadecanoyl-3-glycerophosphorylcholine, 0.624 g of N'-dimethylaminopyridine, and 12 g of dimethyl sulfoxide were added.
- was added and stirred at 50°C for 6 hours.
反応終了後、シリカゲルカラムクロマトにより、最初は
アセトンを展開液として用い、ジメチルスルホキシドを
流出させた。次に、クロロホルム:メタノールエフNア
ンモニア水=60:20: 3 (容積比)を展開液と
して用いることで、目的とする1−オクタデカノイル−
2−(9−((テトラヒドロ−21−1−ビラン−2−
イル)オキシ)ノナノイル)〜3−グリセロホスホリル
コリン1.64g(収率86.5%)を得た。After the reaction was completed, dimethyl sulfoxide was eluted using silica gel column chromatography using acetone as a developing solution. Next, the desired 1-octadecanoyl-
2-(9-((tetrahydro-21-1-bilane-2-
1.64 g (yield: 86.5%) of yl)oxy)nonanoyl)-3-glycerophosphorylcholine was obtained.
マススペクトル、赤外スペクトル及び元素分析の結果は
次の通りであった。The results of mass spectrum, infrared spectrum and elemental analysis were as follows.
マススペクトル(m/z) : 764 ((M+H
)” )1740 (C・0伸縮振動)
元素分析:
(計算値) : C62,91% H10,22%
N 1.83% P 4.06%
(実測値) : C62,12% H11,01%N
1.81% P 4.31%
なお、リン脂質の2位の炭素のエステル結合を特異的に
分解する酵素を用いて、2位の炭素に結合した基を確認
した。Mass spectrum (m/z): 764 ((M+H
)” )1740 (C・0 stretching vibration) Elemental analysis: (calculated value): C62,91% H10,22%
N 1.83% P 4.06% (actual value): C62,12% H11,01%N
1.81% P 4.31% The group bonded to the 2nd carbon position of the phospholipid was confirmed using an enzyme that specifically decomposes the ester bond at the 2nd carbon position.
上記の方法で合成した化合物100■を、へび毒ホスホ
リパーゼA2(naja naja venom; S
IGMA Chew。The compound 100cm synthesized by the above method was treated with snake venom phospholipase A2 (naja naja venom; S
IGMA Chew.
Corp、) 0.3mg、5%CaC1z水溶液0,
1mg及びエチルエーテル10−の混合液に加え、室温
で1晩攪拌して反応させた。反応後、シリカゲル薄層ク
ロマトグラフィー(展開液;クロロホルム:メタノール
:水=65:25:4(容積比))で分離した。R2値
0.90付近の脂肪酸成分のスボ7トを分取してメタノ
ールで抽出した。この脂肪酸成分を常法によりメチルエ
ステル化した後、ガスクロマトグラフィーで分析した結
果、2位の炭素に結合した9−((テトラヒドロ−2H
−ビラン−2−イル)オキシ)ノナン酸が、95.8%
であった。Corp, ) 0.3 mg, 5% CaC1z aqueous solution 0,
It was added to a mixture of 1 mg of ethyl ether and 10 mg of ethyl ether, and the mixture was stirred at room temperature overnight to react. After the reaction, the mixture was separated by silica gel thin layer chromatography (developing solution: chloroform:methanol:water=65:25:4 (volume ratio)). Seven fractions of fatty acid components with an R2 value of around 0.90 were fractionated and extracted with methanol. After methyl esterifying this fatty acid component by a conventional method, gas chromatography analysis revealed that 9-((tetrahydro-2H
-bilan-2-yl)oxy)nonanoic acid, 95.8%
Met.
以上の分析結果より、1−オクタデカノイル−2−(9
−((テトラヒドロ−2H−ピラン−2−イル)オキシ
)ノナノイル−3−グリセロホスホリルコリンが合成さ
れていることを確認した。From the above analysis results, 1-octadecanoyl-2-(9
It was confirmed that -((tetrahydro-2H-pyran-2-yl)oxy)nonanoyl-3-glycerophosphorylcholine was synthesized.
実施例2
9−ヒドロキシノナン酸メチルの代わりに、6−ヒドロ
キシヘキサン酸メチル10.5 gを用い、他の試薬は
実施例1のモル比に従い適量を用い、実験方法を実施例
1に従ったところ、6−((テトラヒドロ−2H−ピラ
ン−2−イル)オキシ)ヘキサン酸メチル11.7g(
収率70.7%)を得た。Example 2 10.5 g of methyl 6-hydroxyhexanoate was used instead of methyl 9-hydroxynonanoate, appropriate amounts of other reagents were used according to the molar ratio of Example 1, and the experimental method was the same as that of Example 1. However, 11.7 g of methyl 6-((tetrahydro-2H-pyran-2-yl)oxy)hexanoate (
A yield of 70.7%) was obtained.
6−((テトラヒドロ−2H−ピラン−2−イル)オキ
シ)ヘキサン酸メチル6.37gを用い、他の試薬は実
施例1のモル比に従い適量を用い、実験方法を実施例1
に従ったところ、6−((テトラヒドロ−2H−ピラン
−2−イル)オキシ)ヘキサン酸4.98g(収率83
.2%)を得た。6.37 g of methyl 6-((tetrahydro-2H-pyran-2-yl)oxy)hexanoate was used, appropriate amounts of other reagents were used according to the molar ratios of Example 1, and the experimental method was changed to Example 1.
According to the results, 4.98 g of 6-((tetrahydro-2H-pyran-2-yl)oxy)hexanoic acid (yield 83
.. 2%).
6−((テトラヒドロ−2H−ビラン−2−イル)オキ
シ)ヘキサン酸を実施例1に従い酸無水物化した。6-((Tetrahydro-2H-bilan-2-yl)oxy)hexanoic acid was converted into an acid anhydride according to Example 1.
1−オクタデカノイル−3−グリセロホスホリルコリン
の代わりに1−ヘキサデカノイル−3−グリセロホスホ
リルコリン1.10gを用い、他の試薬は、実施例10
モル比に従い適量を用いた。実験方法を実施例1と同様
に行ったところ、1−ヘキサデカノイル−2−(6−(
(テトラヒドロ−2H−ビラン−2−イル)オキシ)ヘ
キサノイル)−3−グリセロホスホリルコリン1.29
g(収率83.8%)を得た。1.10 g of 1-hexadecanoyl-3-glycerophosphorylcholine was used instead of 1-octadecanoyl-3-glycerophosphorylcholine, and the other reagents were as in Example 10.
Appropriate amounts were used according to the molar ratio. When the experimental method was carried out in the same manner as in Example 1, 1-hexadecanoyl-2-(6-(
(Tetrahydro-2H-bilan-2-yl)oxy)hexanoyl)-3-glycerophosphorylcholine 1.29
g (yield: 83.8%).
マススペクトル、赤外スペクトル及び元素分析の結果は
次の通りであった。The results of mass spectrum, infrared spectrum and elemental analysis were as follows.
マススペクトル(m/z) : 694 (CM+
H)” )1740 (C=O伸縮振動)
元素分析:
(計算値) : C60,61% H9,81%N
2.02% P 4.47%
(実測値) i C59,71% l−110,3
1%N 1.90% P 4.19%得られたリ
ン脂質の2位の炭素に結合した6−((テトラヒドロ−
2H−ビラン−2−イル)オキシ)ヘキサン酸を実施例
1に従ってガスクロマトグラフィーで分析した結果、9
5,3%であった。Mass spectrum (m/z): 694 (CM+
H)'')1740 (C=O stretching vibration) Elemental analysis: (calculated value): C60, 61% H9, 81%N
2.02% P 4.47% (actual value) i C59,71% l-110,3
1% N 1.90% P 4.19% 6-((tetrahydro-
As a result of gas chromatography analysis of 2H-bilan-2-yl)oxy)hexanoic acid according to Example 1, 9
It was 5.3%.
以上の分析結果より、1−ヘキサデカノイル−2−(6
−((テトラヒドロ−2H−ビラン−2−イル)オキシ
)ヘキサノイル)−3−グリセロホスホリルコリンが合
成されていることが確かめられた。From the above analysis results, 1-hexadecanoyl-2-(6
It was confirmed that -((tetrahydro-2H-bilan-2-yl)oxy)hexanoyl)-3-glycerophosphorylcholine was synthesized.
実施例3
9−ヒドロキシノナン酸メチルの代わりに12−ヒドロ
キシドデカン酸メチル12.01gヲ用い、他ノ試薬は
実施例1のモル比に従い適量を使用した。Example 3 12.01 g of methyl 12-hydroxydodecanoate was used in place of methyl 9-hydroxynonanoate, and appropriate amounts of other reagents were used according to the molar ratios in Example 1.
実験方法を実施例1に従ったところ、12−((テトラ
ヒドロ−2H〜ビラン−2−イル)オキシ)ドデカン酸
メチル9.36g(収率57.1%)を得た。これを7
.83g用い、他の試薬は実施例1のモル比に従い適量
を用い、実験方法を実施例1に従ったところ、12−(
(テトラヒドロ−2H−ビラン−2−イル)オキシ)ド
デカン酸6゜23g(収率83゜3%)を得た。これを
実施例1に従い酸無水物化した。When the experimental method was according to Example 1, 9.36 g (yield 57.1%) of methyl 12-((tetrahydro-2H-bilan-2-yl)oxy)dodecanoate was obtained. This is 7
.. 83g was used, other reagents were used in appropriate amounts according to the molar ratios in Example 1, and the experimental method was in accordance with Example 1. As a result, 12-(
6.23 g (yield: 83.3%) of (tetrahydro-2H-bilan-2-yl)oxy)dodecanoic acid was obtained. This was converted into an acid anhydride according to Example 1.
1−オクタデカノイル−3−グリセロホスホリルコリン
の代わりに1−ドデカノイル−3−グリセロホスホリル
コリン1.15gを用い、他の試薬は、実施例10モル
比に従い適量を用いた。実験方法を実施例1と同様に行
ったところ、l−ドデカノイル〜2− (12−((テ
トラヒドロ−2H−ビラン−2−イル)オキシ) ドデ
カノイル)−3−グリセロホスホリルコリン1.50g
(収率79.4%)を得た。1.15 g of 1-dodecanoyl-3-glycerophosphorylcholine was used in place of 1-octadecanoyl-3-glycerophosphorylcholine, and appropriate amounts of other reagents were used according to the molar ratios in Example 10. The experimental method was carried out in the same manner as in Example 1, and 1.50 g of l-dodecanoyl-2-(12-((tetrahydro-2H-bilan-2-yl)oxy)dodecanoyl)-3-glycerophosphorylcholine was obtained.
(yield 79.4%).
マススペクトル、赤外スペクトル及び元素分析の結果は
次の通りであった。The results of mass spectrum, infrared spectrum and elemental analysis were as follows.
マススペクトル(m/z) : 722 ((M+
H)” )1740 (C=0伸縮振動)
元素分Fr:
(計算値) : C61,58% H9,99%N
1.94% P 4.30%
(実測値) : C61,61% B 10.51%
N 1.71% P 4.03%得られたリン脂
質の2位の炭素に結合した12−((テトラヒドロ−2
H−ビラン−2〜イル)オキシ)ドデカン酸を、実施例
1に従ってガスクロマトグラフィで分析した結果、93
.8%であった。Mass spectrum (m/z): 722 ((M+
H)” )1740 (C=0 stretching vibration) Elemental content Fr: (calculated value): C61,58% H9,99%N
1.94% P 4.30% (actual value): C61,61% B 10.51%
N 1.71% P 4.03% 12-((tetrahydro-2
As a result of analyzing H-bilan-2-yl)oxy)dodecanoic acid by gas chromatography according to Example 1, 93
.. It was 8%.
以上の分析結果より、l−ドデカノイル−2−(12−
((テトラヒドロ−2H−ビラン−2−イル)オキシ)
ドデカノイル−3−グリセロホスホリルコリンが合成さ
れていることが確かめられた。From the above analysis results, l-dodecanoyl-2-(12-
((tetrahydro-2H-bilan-2-yl)oxy)
It was confirmed that dodecanoyl-3-glycerophosphorylcholine was synthesized.
実施例4
攪拌子の入った5〇−活栓付ナス型フラスコに、9−(
(テトラヒドロ−2H−ビラン−2−イル)オキシ)ノ
ナン酸無水物2.582g、 4−ジメチルアミノピリ
ジン0.647g、 1−オクタデカノイル−3−グリ
セロホスホリルコリン1.585g及びジメチルスルホ
キシド10dを加え、50℃で7.5時間反応させた。Example 4 9-(
Add 2.582 g of (tetrahydro-2H-bilan-2-yl)oxy)nonanoic anhydride, 0.647 g of 4-dimethylaminopyridine, 1.585 g of 1-octadecanoyl-3-glycerophosphorylcholine and 10 d of dimethyl sulfoxide, The reaction was carried out at 50°C for 7.5 hours.
反応終了後、反応混合物をシリカゲルカラムクロマト(
展開液;アセトンの後、クロロホルム:メタノールニア
Nアンモニア水−60:20:3(容積比))により分
離し、1−オクタデカノイル−2−(9−((テトラヒ
ドロ−2H−ビラン−2−イル)オキシ)ノナノイル)
−3−グリセロホスホリルコリン2.003g(収率8
6.5%)を得た。After the reaction is complete, the reaction mixture is subjected to silica gel column chromatography (
Developing solution: acetone, followed by separation with chloroform: methanol, N, aqueous ammonia - 60:20:3 (volume ratio)), and 1-octadecanoyl-2-(9-((tetrahydro-2H-bilan-2- yl)oxy)nonanoyl)
-3-glycerophosphorylcholine 2.003g (yield 8
6.5%).
次に撹拌子の入った100 d活栓付ナス型フラスコに
1−オクタデカノイル−2−(9−((テトラヒドロ−
2H−ビラン−2−イル)オキジ)ノナノイル)−3−
グリセロホスホリルコリン0.712g及び85%酢酸
水溶液50−を加え、40℃で3時間反応させた。Next, 1-octadecanoyl-2-(9-((tetrahydro-
2H-bilan-2-yl)oxy)nonanoyl)-3-
0.712 g of glycerophosphorylcholine and 50% of an 85% acetic acid aqueous solution were added, and the mixture was reacted at 40°C for 3 hours.
反応終了後、反応混合液を濃縮し、シリカゲルカラムク
ロマト(展開液;クロロホルム:メタノール:水−2:
5:1 (容積比))を用いて分離した。その結果l
−オクタデカノイル−2−(9−ヒドロキシノナノイル
)−3−グリセロホスホリルコリン0.366g(収率
57.8%)を得た。After the reaction, the reaction mixture was concentrated and subjected to silica gel column chromatography (developing solution: chloroform:methanol:water-2:
5:1 (volume ratio)). The result l
-Octadecanoyl-2-(9-hydroxynonanoyl)-3-glycerophosphorylcholine 0.366 g (yield 57.8%) was obtained.
マススペクトル、赤外スペクトル及び元素分析の結果は
次の通りであった。The results of mass spectrum, infrared spectrum and elemental analysis were as follows.
マススペクトル(si/z) : 680 ((M
+H]” )1740 (C・0伸縮振動)
3400 (0−H伸縮振動)
元素分析:
(計算値) : C61,86% 810.46%
N 2.06% P 4.57%
(実測値) : C62,11% )l 10.69
%N 1.98% P 4.39%
なお、4リン脂質の2位のエステル結合を特異的に分解
する酵素を用いて、2位の炭素に結合した基を確認した
。Mass spectrum (si/z): 680 ((M
+H]”) 1740 (C・0 stretching vibration) 3400 (0-H stretching vibration) Elemental analysis: (Calculated value): C61.86% 810.46%
N 2.06% P 4.57% (measured value): C62,11%)l 10.69
%N 1.98% P 4.39% The group bonded to the carbon at the 2-position was confirmed using an enzyme that specifically decomposes the ester bond at the 2-position of the 4-phospholipid.
上記の方法で合成した化合物100■を、へび毒ホスホ
リパーゼAt(naja naja venom; S
IGMA Che+w。The compound 100cm synthesized by the above method was treated with snake venom phospholipase At (naja naja venom; S
IGMA Che+w.
Corp、) 0.3w、5%CaC1z水溶液0.1
d及びジエチルエーテルtoyの混合液に加え、室温で
1晩攪拌して反応させた。Corp, ) 0.3w, 5% CaClz aqueous solution 0.1
d and diethyl ether toy, and the mixture was stirred at room temperature overnight to react.
反応後、シリカゲル薄層クロマトグラフィー(展開液;
クロロホルム:メタノール:酢酸:水=so:2s:8
: 4 (容積比))で分離した。R2値0.85付
近の脂肪酸成分のスポットを分取して、メタノールで抽
出した。この脂肪酸成分を常法によりエステル化した後
ガスクロマトグラフィーで分析した結果、標品の9−ヒ
ドロキシノナン酸を同様にエステル化した化合物と同じ
ピークが93.8%の純度で得られた。After the reaction, silica gel thin layer chromatography (developing solution;
Chloroform:methanol:acetic acid:water=so:2s:8
: 4 (volume ratio)). A spot containing fatty acid components with an R2 value of around 0.85 was fractionated and extracted with methanol. This fatty acid component was esterified by a conventional method and then analyzed by gas chromatography. As a result, the same peak as that of a compound obtained by similarly esterifying standard 9-hydroxynonanoic acid was obtained with a purity of 93.8%.
以上の分析結果より、l−オクタデカノイル−2−(9
−ヒドロキシノナノイル)−3−グリセロホスホリルコ
リンが合成されていることが確かめられた。From the above analysis results, l-octadecanoyl-2-(9
It was confirmed that -hydroxynonanoyl)-3-glycerophosphorylcholine was synthesized.
実施例5
9−((テトラヒドロ−2H−ビラン−2−イル)オキ
シ)ノナン酸無水物の代わりに、6−((テトラヒドロ
−2H−ビラン−2−イル)オキシ)ヘキサン酸無水物
1.63 gを、また1−オクタデカノイル−3−グリ
セロホスホリルコリンの代わりに、1−ヘキサデカノイ
ル−3−グリセロホスホリルコリン0.981g、およ
び4−ジメチルアミノピリジン0.485gを用いた以
外は、実施例4と同様な条件で反応させ、同様な操作方
法により、目的の1−ヘキサデカノイル−2−(6−ヒ
ドロキシヘキサノイル)−3−グリセロホスホリルコリ
ン0.725g(収率60.1%)を得た。Example 5 6-((tetrahydro-2H-bilan-2-yl)oxy)hexanoic anhydride 1.63 instead of 9-((tetrahydro-2H-bilan-2-yl)oxy)nonanoic anhydride Example 4, except that 0.981 g of 1-hexadecanoyl-3-glycerophosphorylcholine and 0.485 g of 4-dimethylaminopyridine were used instead of 1-octadecanoyl-3-glycerophosphorylcholine. 0.725 g (yield: 60.1%) of the target 1-hexadecanoyl-2-(6-hydroxyhexanoyl)-3-glycerophosphorylcholine was obtained by reacting under the same conditions as above and using the same operating method. .
マススペクトル、赤外スペクトル、元素分析の結果は次
の通りであった。The results of mass spectrum, infrared spectrum, and elemental analysis were as follows.
マススペクトル(m/z) : 610 ((M+
H)” )1740 (C=0伸縮振動)
3400 (0−H伸縮振動)
元素分析:
(計算値) : C59,11% H9,85%N
2.30% P 5.09%
(実測値) : C58,78% H10,03%
N 2.19% P 5.01%
なお、リン脂質の2位の炭素のエステル結合を特異的に
分解する酵素を用いて、2位の炭素に結合した基を実施
例4と同様に確認した。その結果2位の6−ヒドロキシ
ヘキサン酸の純度が、95.1%であることが、ガスク
ロマトグラフィーによりわかった。Mass spectrum (m/z): 610 ((M+
H)") 1740 (C=0 stretching vibration) 3400 (0-H stretching vibration) Elemental analysis: (calculated value): C59,11% H9,85%N
2.30% P 5.09% (actual value): C58,78% H10,03%
N 2.19% P 5.01% In addition, the group bonded to the carbon position 2 was confirmed in the same manner as in Example 4 using an enzyme that specifically decomposes the ester bond at the carbon position 2 of the phospholipid. . As a result, it was found by gas chromatography that the purity of 6-hydroxyhexanoic acid at the second position was 95.1%.
以上の分析結果より、1−ヘキサデカノイル−2−(6
−ヒドロキシヘキサノイル)−3−グリセロホスホリル
コリンが合成されていることが確かめられた。From the above analysis results, 1-hexadecanoyl-2-(6
It was confirmed that -hydroxyhexanoyl)-3-glycerophosphorylcholine was synthesized.
実施例6
9−((テトラヒドロ−2H−ビラン−2−イル)オキ
シ)ノナン酸無水物の代わりに、12−((テトラヒド
ロ−2H−ビラン−2−イル)オキシ)ドデカン酸無水
物1.71gを、又、l−オクタデカノイル−3−グリ
セロホスホリルコリンの代わりに1−デカノイル−3−
グリセロホスホリルコリン0.681g、4−ジメチル
アミノピリジン0.353gを用いた他は実施例4に述
べた方法と同様の条件で反応させ、同様な操作により目
的の1−デカノイル−2−(12−ヒドロキシドデカノ
イル)−3−グリセロホスホリルコリン0.435g(
収率43.1%)を得た。Example 6 1.71 g of 12-((tetrahydro-2H-bilan-2-yl)oxy)dodecanoic anhydride instead of 9-((tetrahydro-2H-bilan-2-yl)oxy)nonanoic anhydride and 1-decanoyl-3-instead of l-octadecanoyl-3-glycerophosphorylcholine.
The reaction was carried out under the same conditions as described in Example 4, except that 0.681 g of glycerophosphorylcholine and 0.353 g of 4-dimethylaminopyridine were used, and the desired 1-decanoyl-2-(12-hydroxy dodecanoyl)-3-glycerophosphorylcholine 0.435g (
A yield of 43.1%) was obtained.
マススペクトル、赤外スペクトル及び元素分析の結果は
次の通りであった。The results of mass spectrum, infrared spectrum and elemental analysis were as follows.
マススペクトル(m/z) 二610 ((M+H
)” )1740 (C・0伸縮振動)
3400 (0−H伸縮振動)
元素分析:
(計算値) : C59,11% 8 9.85%
N 2.30% P 5.09%
(実測値): C59,01% H9,92%N
2.50% P 4.87%
なお、リン脂質の2位の炭素に結合した基を実施例4と
同様な方法により測定したところ、12−ヒドロキシド
デカン酸の純度が、95.3%であることがガスクロマ
トグラフィーによりわかった。Mass spectrum (m/z) 2610 ((M+H
)” )1740 (C・0 stretching vibration) 3400 (0-H stretching vibration) Elemental analysis: (Calculated value): C59,11% 8 9.85%
N 2.30% P 5.09% (measured value): C59.01% H9.92%N
2.50% P 4.87% When the group bonded to the carbon 2 position of the phospholipid was measured using the same method as in Example 4, the purity of 12-hydroxydodecanoic acid was 95.3%. This was confirmed by gas chromatography.
以上の分析結果より1−デカノイル−2−(12−ヒド
ロキシドデカノイル)−3−グリセロホスホリルコリン
が合成されていることが確かめられた。From the above analysis results, it was confirmed that 1-decanoyl-2-(12-hydroxydodecanoyl)-3-glycerophosphorylcholine was synthesized.
比較例1
9−((テトラヒドロ−2H−ピラン−2−イル)オキ
シ)ノナン酸無水物の代わりに、9−ヒドロキシノナン
酸と、N、N′−ジシクロへキシルカルボジイミドの混
合物を用いた他は実施例4に従って操作を行ったところ
、1−オクタデカノイル−2−(9−ヒドロキシノナノ
イル)−3−グリセロホスホリルコリンは得られなかっ
た。Comparative Example 1 A mixture of 9-hydroxynonanoic acid and N,N'-dicyclohexylcarbodiimide was used instead of 9-((tetrahydro-2H-pyran-2-yl)oxy)nonanoic anhydride. When the operation was carried out according to Example 4, 1-octadecanoyl-2-(9-hydroxynonanoyl)-3-glycerophosphorylcholine was not obtained.
比較例2
9−((テトラヒドロ−2H−ピラン−2−イル)オキ
シ)ノナン酸無水物の代わりに、9−アセトキシノナン
酸無水物を用いた他は実施例4に従い操作を行ったとこ
ろ、アセチル基を選択的に除去することが困難なため、
1−オクタデカノイル−2−(9−ヒドロキシノナノイ
ル)−3−グリセロホスホリルコリンは得られなかった
。Comparative Example 2 The procedure of Example 4 was followed except that 9-acetoxynonanoic anhydride was used instead of 9-((tetrahydro-2H-pyran-2-yl)oxy)nonanoic anhydride. Because it is difficult to selectively remove groups,
1-octadecanoyl-2-(9-hydroxynonanoyl)-3-glycerophosphorylcholine was not obtained.
Claims (4)
れるリン脂質誘導体。(1) A phospholipid derivative represented by the following general formula: ▲Mathematical formula, chemical formula, table, etc. ▼(I) (In the formula, m is 1 to 22 and n is 1 to 22.)
れるリン脂質誘導体。(2) A phospholipid derivative represented by the following general formula: ▲Mathematical formula, chemical formula, table, etc.▼(II) (In the formula, m is 1 to 22 and n is 1 to 22.)
リンと、次の一般式: ▲数式、化学式、表等があります▼(IV) (式中、nは1〜22である。) で表される保護基を有する脂肪酸無水物とを反応させ請
求項2記載のリン脂質誘導体(II)を得ることを特徴と
するリン脂質誘導体の製造方法。(3) 1-monoacyl-3-glycerophosphorylcholine represented by the following general formula ▲ Numerical formulas, chemical formulas, tables, etc. ▼ (III) (In the formula, m is 1 to 22) and the following general formula: Formula: ▲There are mathematical formulas, chemical formulas, tables, etc.▼(IV) (In the formula, n is 1 to 22.) The phospholipid according to claim 2, which is reacted with a fatty acid anhydride having a protecting group represented by A method for producing a phospholipid derivative, the method comprising obtaining a derivative (II).
リンと、次の一般式: ▲数式、化学式、表等があります▼(IV) (式中、nは1〜22である。) で表される保護基を有する脂肪酸無水物とを反応させ請
求項2記載のリン脂質誘導体(II)を得た後、これを酸
処理して請求項1記載のリン脂質誘導体( I )を得る
ことを特徴とするリン脂質誘導体の製造方法。(4) 1-monoacyl-3-glycerophosphorylcholine represented by the following general formula ▲ Numerical formulas, chemical formulas, tables, etc. ▼ (III) (In the formula, m is 1 to 22) and the following general formula: Formula: ▲There are mathematical formulas, chemical formulas, tables, etc.▼(IV) (In the formula, n is 1 to 22.) The phospholipid according to claim 2, which is reacted with a fatty acid anhydride having a protecting group represented by A method for producing a phospholipid derivative, which comprises obtaining the derivative (II) and then treating it with an acid to obtain the phospholipid derivative (I) according to claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63083136A JPH01258691A (en) | 1988-04-06 | 1988-04-06 | Phospholipid derivative and production thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63083136A JPH01258691A (en) | 1988-04-06 | 1988-04-06 | Phospholipid derivative and production thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH01258691A true JPH01258691A (en) | 1989-10-16 |
Family
ID=13793787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63083136A Pending JPH01258691A (en) | 1988-04-06 | 1988-04-06 | Phospholipid derivative and production thereof |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH01258691A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007531706A (en) * | 2003-05-27 | 2007-11-08 | ヴァスキュラー バイオジェニックス リミテッド | Oxidized lipids and their use in the treatment of inflammatory diseases and disorders |
| EP1341543A4 (en) * | 2000-11-24 | 2009-09-02 | Vascular Biogenics Ltd | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| US8569529B2 (en) | 2007-01-09 | 2013-10-29 | Vascular Biogenics Ltd. | High-purity phospholipids |
| US8759557B2 (en) | 2004-07-09 | 2014-06-24 | Vascular Biogenics Ltd. | Process for the preparation of oxidized phospholipids |
| US9006217B2 (en) | 2007-01-09 | 2015-04-14 | Vascular Biogenics Ltd. | High-purity phospholipids |
| US9206206B2 (en) | 2008-11-06 | 2015-12-08 | Vascular Biogenics Ltd. | Oxidized lipid compounds and uses thereof |
| US9771385B2 (en) | 2014-11-26 | 2017-09-26 | Vascular Biogenics Ltd. | Oxidized lipids |
| US10022388B2 (en) | 2014-11-26 | 2018-07-17 | Vascular Biogenics Ltd. | Oxidized lipids and treatment or prevention of fibrosis |
-
1988
- 1988-04-06 JP JP63083136A patent/JPH01258691A/en active Pending
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1341543A4 (en) * | 2000-11-24 | 2009-09-02 | Vascular Biogenics Ltd | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| US7893291B2 (en) | 2000-11-24 | 2011-02-22 | Vascular Biogenics Ltd. | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| US8563534B2 (en) | 2000-11-24 | 2013-10-22 | Vascular Biogenics Ltd. | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| JP2007531706A (en) * | 2003-05-27 | 2007-11-08 | ヴァスキュラー バイオジェニックス リミテッド | Oxidized lipids and their use in the treatment of inflammatory diseases and disorders |
| EP1626728A4 (en) * | 2003-05-27 | 2009-09-02 | Vascular Biogenics Ltd | OXIDE LIPIDS AND THEIR USE IN THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS |
| US7902176B2 (en) | 2003-05-27 | 2011-03-08 | Vascular Biogenics Ltd. | Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| US7973023B2 (en) | 2003-05-27 | 2011-07-05 | Vascular Biogenics Ltd. | Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| US8759557B2 (en) | 2004-07-09 | 2014-06-24 | Vascular Biogenics Ltd. | Process for the preparation of oxidized phospholipids |
| US8802875B2 (en) | 2004-07-09 | 2014-08-12 | Vascular Biogenics Ltd. | Process for the preparation of oxidized phospholipids |
| US8569529B2 (en) | 2007-01-09 | 2013-10-29 | Vascular Biogenics Ltd. | High-purity phospholipids |
| US9006217B2 (en) | 2007-01-09 | 2015-04-14 | Vascular Biogenics Ltd. | High-purity phospholipids |
| US9566288B2 (en) | 2007-01-09 | 2017-02-14 | Vascular Biogenics Ltd. | High-purity phospholipids |
| US9206206B2 (en) | 2008-11-06 | 2015-12-08 | Vascular Biogenics Ltd. | Oxidized lipid compounds and uses thereof |
| US9771385B2 (en) | 2014-11-26 | 2017-09-26 | Vascular Biogenics Ltd. | Oxidized lipids |
| US10022388B2 (en) | 2014-11-26 | 2018-07-17 | Vascular Biogenics Ltd. | Oxidized lipids and treatment or prevention of fibrosis |
| US10206936B2 (en) | 2014-11-26 | 2019-02-19 | Vascular Biogenics Ltd. | Oxidized lipids and treatment or prevention of fibrosis |
| US10464957B2 (en) | 2014-11-26 | 2019-11-05 | Vascular Biogenics Ltd. | Oxidized lipids and methods of use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6147236A (en) | Preparation of sterol and stanol-esters | |
| RU2566826C1 (en) | Method of producing 1-palmitoyl-3-acetylglycerine and method of producing 1-palmitoyl-2-linoleoyl-3-acetylglycerine using said compound | |
| EP0982315A2 (en) | Preparation of sterol and stanol esters | |
| JPH01258691A (en) | Phospholipid derivative and production thereof | |
| EP0063106B1 (en) | Process for preparing high purity ursodeoxycholic acid | |
| DE69222643T2 (en) | METHOD FOR PRODUCING DEMETHYLEPYPODOPHYLLOTOXIN | |
| JP3648740B2 (en) | 2,3-didehydrosialic acid substituted at position 7 with fluorine and its synthetic intermediate | |
| JPWO1995032955A1 (en) | 2,3-didehydrosialic acid substituted with fluorine at the 7-position and its synthetic intermediate | |
| JP2004307476A (en) | Method for preparing O-acylated glucose derivative | |
| US6130354A (en) | Process for the preparation of shikimic acid and its derivatives | |
| JPH0248585A (en) | Phospholipid derivative and production thereof | |
| JPS63135395A (en) | Phospholipid derivative and production thereof | |
| JP4677550B2 (en) | Cyclic ester compound | |
| Watanabe et al. | Proximately Assisted and Chemoselectively Cleavable Protecting Groups for Alcohols, 2-(2-(Arylmethyloxy) ethyl) benzoic Esters. | |
| JPH0684367B2 (en) | New method for producing forskolin derivative | |
| JPH06293789A (en) | Polyunsaturated fatty acid glycosides and method for producing the same | |
| JPS63188692A (en) | Production of phospholipid derivative | |
| EP0332191A2 (en) | Sialosyl glyceride and process for producing the same | |
| JPS6241720B2 (en) | ||
| EP0582153B1 (en) | Method of preparing 4-deoxy-D-mannose | |
| JPS63215685A (en) | Production of phospholipid derivative | |
| JPS60130539A (en) | Preparation of optically active styrene halohydrin | |
| SU1474159A1 (en) | Method of producing ethoxymalonyl chloride | |
| JP2538231B2 (en) | Process for producing optically active 4-pentene-2-ol derivative | |
| JPH08119987A (en) | Gla-60 analog |